Subacute Sclerosing Panencephalitis

Slide 1 · Subacute sclerosing panencephalitis

Delayed measles-associated neurodegenerative encephalitis

Remote measles infection

Persistent CNS infection

Progressive neurologic decline

An uncommon but largely fatal late complication of measles

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Explain why remote measles infection can cause delayed encephalitis.

Connect viral persistence to neuronal injury, gliosis, and demyelination.

Interpret clinical evolution, CSF measles antibodies, EEG, and MRI.

Differentiate SSPE from mimics and explain prevention.

Slide 3 · Core definition and diagnostic identity

SSPE is a progressive inflammatory–degenerative disorder of the CNS after measles infection.

Disease onset follows an often prolonged clinically silent interval.

Cognitive deterioration and myoclonus are important clues, not universal entry symptoms.

Measles-specific intrathecal antibody synthesis is central to diagnosis.

Slide 4 · The long interval is the defining temporal clue

Acute measles

Apparent recovery

Clinically silent years

Progressive CNS disease

Typical latency is years; CDC describes 7–10 years after measles.

The interval and clinical presentation are variable; Remote infection may be forgotten.

Slide 5 · SSPE is not acute measles encephalitis

Acute measles encephalitis accompanies or shortly follows primary infection.

SSPE arises years after the original illness, often without acute systemic symptoms.

The pathology of SSPE reflects persistent brain infection and progressive tissue injury.

Timing is a practical first discriminator when reviewing post-measles neurologic disorders.

Slide 6 · SSPE in the spectrum of measles neurologic disease

Entity

Approximate timing

Dominant concept

Acute measles encephalitis

During or soon after measles

Acute CNS complication

Postinfectious ADEM

Days to weeks after infection

Inflammatory demyelinating syndrome

Measles inclusion-body encephalitis

Often immunocompromised host

Progressive direct viral encephalitis

SSPE

Years after measles

Persistent-virus panencephalitis

These syndromes differ in timing, host context, and dominant pathogenesis.

Slide 7 · Who is at risk?

SSPE is uncommon relative to the number of measles infections.

Measles infection at a very young age is associated with greater subsequent SSPE risk.

Most recognized cases present during childhood or adolescence; Adult presentations occur.

Population-level risk is context dependent; Avoid applying one estimate universally.

Slide 8 · Epidemiologic context changes with vaccination

Measles incidence and transmission determine the pool at risk for later SSPE.

The latent interval means SSPE cases can appear long after an outbreak.

Sustained vaccination reduces measles infections and therefore prevents later SSPE.

Clinical vigilance remains important in regions with measles transmission.

Slide 9 · What does “persistent infection” mean here?

The initiating event is infection with measles virus, an enveloped RNA virus.

Viral genetic material and proteins can persist within CNS cells.

Continued intracellular infection differs from an ordinary acute viremic illness.

The exact initial route into and establishment within brain tissue remain incompletely resolved.

Slide 10 · Neurons and glia are the key injured compartments

Neuron

Oligodendrocyte

Astrocyte

Simplified cell schematic — not a histologic image

Intracellular viral material occurs in neurons and glial cells.

Slide 11 · Measles virus: The structural proteins that matter

Matrix (M) protein supports virion assembly and release.

Fusion (F) protein mediates membrane fusion.

Hemagglutinin (H) attachment protein participates in receptor interactions.

Nucleocapsid proteins package viral RNA and may accumulate as inclusions.

Slide 12 · Defective assembly may favor intracellular persistence

Mechanistic sequence

Altered M function

Reduced conventional virion assembly/release

Intracellular persistence and spread

M-protein defects are implicated in SSPE virus biology, but mechanistic variation exists.

Slide 13 · Fusion-protein adaptations facilitate neural spread

Mechanistic sequence

Changes in F protein

Altered membrane-fusion activity

Cell-to-cell viral propagation

A hyperfusogenic phenotype has been documented in experimental models of SSPE-associated variants.

Slide 14 · Measles neurotropism is biologically complex

Canonical measles receptors do not fully explain spread among mature neurons.

Laboratory work supports roles for altered viral proteins and neuronal host factors.

The contribution of individual M, F, and H mutations differs across studied viral genomes.

Do not reduce a heterogeneous disease to one obligatory mutation.

Slide 15 · Cell-to-cell spread helps explain persistence

Mechanistic sequence

Infected CNS cell

Intercellular transfer

Newly infected CNS cell

The schematic describes a proposed dominant route, not a patient-derived microscopic observation.

Slide 16 · Why antibodies do not necessarily clear the virus

Measles-specific antibodies can be abundant in serum and CSF.

Antibody presence is therefore not equivalent to elimination of intracellular infection.

Cell-associated viral spread may restrict exposure to neutralizing antibodies.

Both persistent infection and host inflammatory responses contribute to injury.

Slide 17 · Inflammation is part of the lesion

Chronic inflammatory infiltrates may involve meninges and brain parenchyma.

Perivascular lymphocytes accompany inflammatory tissue injury.

Astrocytic and microglial responses may amplify local damage.

Inflammation does not exclude an underlying persistent viral etiology.

Slide 18 · Mechanistic links to white matter injury

Mechanistic sequence

Infected glia / inflammatory injury

Myelin damage

Disconnection and neurologic deficits

Demyelination is part of SSPE pathology, not its only tissue abnormality.

Slide 19 · Neuronal injury produces irreversible deficits

Neuronal dysfunction can precede frank tissue loss.

Progressive neuronal loss helps explain advancing cognitive and motor impairment.

Reactive astrocytosis and tissue sclerosis accompany chronic injury.

The distribution and timing of injury vary among patients.

Slide 20 · From persistent measles to panencephalitis

Mechanistic sequence

Persistent viral activity

Glial + neuronal injury

Inflammation + demyelination

Functional decline

This is a teaching synthesis; Mechanisms are not a single proven linear pathway.

Slide 21 · Early clinical disease can be deceptively subtle

Declining school performance or altered work function may be the first sign.

Personality change, poor concentration, or impaired memory can precede severe movement abnormalities.

A normal early MRI or atypical EEG does not eliminate SSPE.

Collateral history helps establish the slope of deterioration.

Slide 22 · The cognitive and behavioral phenotype

Memory, attention, executive function, and learning may deteriorate.

Behavioral changes may be interpreted initially as psychiatric or educational problems.

Progression over weeks to months should prompt assessment for organic brain disease.

Clinical decline often becomes multi-domain rather than isolated.

Slide 23 · Myoclonus is a characteristic bedside clue

Sudden involuntary jerks may be generalized, focal, or segmental.

Some patients exhibit periodic, stereotyped motor events.

Myoclonus can produce repeated falls and loss of functional independence.

The phenomenon may coincide with characteristic periodic EEG complexes.

Slide 24 · SSPE has a broad movement-disorder spectrum

Hyperkinetic features reported include dystonia, chorea, tremor, and tics.

Hypokinetic manifestations include parkinsonism and rigidity.

Ataxia and other coordination abnormalities may coexist.

Atypical motor syndromes should not obscure the underlying progressive encephalopathy.

Slide 25 · Seizures and epileptic phenomena

Epileptic seizures can occur during SSPE and may be an early presentation.

Not every abnormal jerk is equivalent to a discrete epileptic seizure.

EEG helps characterize both periodic complexes and superimposed epileptic activity.

Clinical–electrophysiologic correlation is essential for accurate interpretation.

Slide 26 · Visual involvement expands the clinical spectrum

Visual complaints or impaired visual processing can precede obvious cognitive decline.

Retinal, optic nerve, and cortical visual manifestations have been described.

Visual deterioration should trigger consideration of CNS pathology, not just ocular disease.

An ophthalmic presentation may delay recognition of SSPE.

Slide 27 · Progressive motor disability

Increasing abnormal movements and rigidity impair activities of daily living.

Spasticity, impaired gait, falls, and swallowing difficulties may develop.

Late stages can include paralysis and loss of responsiveness.

Functional decline reflects multifocal cerebral pathology.

Slide 28 · The clinical course is progressive, not uniform

Early cognitive change

Myoclonus / seizures

Rigidity and disability

Unresponsiveness

This ordered sequence is typical but not obligatory.

Relapsing, rapidly progressive, or atypical courses are reported.

Slide 29 · Clinical stage I: Subtle higher-function loss

Behavioral, personality, or intellectual changes predominate.

School or occupational decline may exceed neurologic examination findings.

Early-stage disease is easily misclassified as functional or psychiatric.

Interpret stages as descriptive clinical constructs rather than rigid biologic phases.

Slide 30 · Clinical stage II: Myoclonus and motor signs

Myoclonic jerks become conspicuous in many typical cases.

Motor coordination, gait, and seizure control may worsen.

Functional dependence increases.

Clinical staging systems vary; No single transition time is universal.

Slide 31 · Clinical stage III: Severe neurologic impairment

Rigidity, extrapyramidal signs, and progressive motor dysfunction become prominent.

Communication and self-care may be profoundly impaired.

Cognitive decline and swallowing or mobility problems increase care requirements.

Advanced disease may involve profound cortical and subcortical dysfunction.

Slide 32 · Clinical stage IV: Terminal dysfunction

Patients may become unresponsive or enter a vegetative state.

Severe rigidity, autonomic disturbances, and profound disability may occur.

Supportive and palliative interventions become central to care.

Disease is usually fatal despite occasional protracted courses.

Slide 33 · Staging is descriptive—not a diagnostic test

Not all patients traverse stages in textbook order.

Fulminant presentations can compress the course.

Unusual age, isolated seizures, or visual symptoms can mask early SSPE.

Diagnostic reasoning must integrate laboratory and electrophysiologic evidence.

Slide 34 · Recognize atypical presentations

Acute or rapidly progressive clinical deterioration may occur.

Some cases initially present with seizures, ataxia, visual impairment, or psychiatric features.

Rare adult presentations complicate the age-based heuristic.

Persistent suspicion is warranted when the objective findings converge.

Slide 35 · Initial assessment: Three questions

Is this a progressive encephalopathy rather than a stationary deficit?

Is there remote measles exposure or residence in a setting with measles transmission?

Are myoclonus, characteristic EEG activity, and intrathecal measles antibodies present?

Investigate treatable alternatives in parallel.

Slide 36 · Diagnostic workup should be convergent

Mechanistic sequence

Clinical trajectory

CSF antibody evidence

EEG ± MRI support

Integrate / exclude mimics

No isolated positive serum measles IgG result establishes SSPE.

Slide 37 · CSF examination: Why the antibody response matters

CSF may have a normal or only mildly increased cellular count.

Total protein and glucose can be relatively unremarkable.

An elevated measles-specific antibody response is a central diagnostic feature.

Assess paired serum and CSF when an antibody index is available.

Slide 38 · Intrathecal synthesis versus passive transfer

CSF measles IgG must be interpreted in the context of serum antibodies.

Paired CSF and serum can support evidence of intrathecal measles-specific synthesis.

A high serum measles IgG titer alone primarily documents previous immunity or infection.

Laboratory methods and reference limits vary; Do not transpose thresholds across assays.

Slide 39 · Serum seropositivity is not diagnostic

Most vaccinated or previously infected people have measles antibodies.

A positive serum assay therefore lacks disease specificity for SSPE.

A compatible clinical syndrome plus a CSF-specific response is more informative.

Avoid conflating evidence of prior exposure with evidence of current CNS disease.

Slide 40 · CSF virologic PCR has limitations

CSF RNA testing may be negative despite proven SSPE.

Predominantly cell-associated infection limits release of detectable viral material.

Negative CSF measles PCR must not overrule compelling clinical and antibody evidence.

Tissue molecular analysis is reserved for selected difficult cases.

Slide 41 · Typical EEG: Periodic generalized complexes

Classical periodic high-amplitude slow-wave complexes are termed Radermecker complexes.

Events may be bilaterally synchronous and stereotyped.

They can accompany periodic myoclonic jerks.

Frequency and morphology vary by disease stage and patient.

Slide 42 · What periodicity means on EEG

Stereotyped generalized complexes can recur at regular intervals; Clinical EEG patterns vary.

Slide 43 · EEG pitfalls in the early or atypical course

A normal or nonspecific EEG does not exclude early SSPE.

Periodic complexes may be absent or atypical at an individual recording.

Repetition and clinical correlation can be appropriate when suspicion remains.

Consider seizures and metabolic or toxic encephalopathy as alternative explanations for periodicity.

Slide 44 · MRI: Characteristic patterns, not a stand-alone test

Initial MRI may be normal.

T2/FLAIR white matter hyperintensities can emerge during disease evolution.

Posterior subcortical and periventricular involvement is commonly described.

Progressive cerebral atrophy may dominate later neuroimaging.

Slide 45 · How imaging relates to pathology

White-matter signal abnormalities are compatible with myelin and tissue injury.

Atrophy is consistent with cumulative loss of brain parenchyma.

Imaging distribution is variable and neither specific nor perfectly stage correlated.

MRI should complement, not replace, clinical and CSF assessment.

Slide 46 · Modified Dyken criteria: Major elements

Major: Clinical syndrome

Typical progressive deterioration or recognized atypical clinical evolution.

Includes unusual age or seizure-led presentations.

Major: Measles antibody evidence

Elevated anti-measles antibodies, particularly in CSF.

Assay-specific interpretation is essential.

Published modified criteria generally require both major elements plus supporting evidence.

Slide 47 · Modified Dyken criteria: Ancillary elements

Supporting feature

Diagnostic contribution

EEG periodic complexes

Characteristic but not universally present

Increased CSF immunoglobulin / globulin

Evidence of intrathecal immune response

Compatible brain histopathology

Invasive confirmation in selected cases

Molecular demonstration of altered measles genome

Specialized confirmatory evidence

Slide 48 · How to apply diagnostic criteria responsibly

Use the published version of a criteria set consistently.

The modified Dyken formulation is a structured framework, not an infallible gold standard.

Serum titers, CSF assays, and ancillary test performance are context dependent.

Cases with atypical features may require referral or specialized molecular/pathologic investigation.

Slide 49 · Approach to a suspected case

Mechanistic sequence

Establish progression + history

CSF measles antibody assessment

EEG and MRI

Evaluate alternatives / decide

The pattern of evidence matters more than an isolated test result.

Slide 50 · Differential diagnosis: Progressive encephalopathy

Comparator

Shared features

Useful discriminators

Autoimmune encephalitis

Behavior change; Seizures

Time course, antibodies, CSF profile

ADEM

Encephalopathy; White-matter lesions

Postinfectious short latency; Acute inflammatory course

Progressive multifocal leukoencephalopathy

White-matter disease

Immunosuppression; JC polyomavirus context

Other prion / degenerative disorders

Rapid cognitive decline; Myoclonus

Age, course, CSF/EEG and disease-specific testing

Slide 51 · ADEM versus SSPE after measles

ADEM is primarily a monophasic immune-mediated demyelinating disorder.

ADEM arises much closer to the inciting infection than SSPE.

SSPE typically has a years-long latency and progressively worsening course.

Measles-specific intrathecal antibodies and classical periodic EEG support SSPE.

Slide 52 · PML versus SSPE

Both can produce progressive neurologic deficits and abnormal white matter.

PML is associated with JC polyomavirus, especially in immunosuppressed hosts.

SSPE links to remote measles infection and progressive cognitive–myoclonic syndrome.

Etiologic testing and host history distinguish the disorders.

Slide 53 · The brain lesion is a panencephalitis

Grey matter and white matter can both be affected.

Microscopic inflammation involves the neuropil and perivascular compartments.

Demyelination and neuronal pathology coexist.

The name captures widespread inflammatory–degenerative involvement.

Slide 54 · Gross pathology may be nonspecific

Gross abnormalities are not required for an early diagnosis.

Advanced cases may show reduced brain volume and cortical atrophy.

Distribution and severity reflect duration and affected CNS regions.

Microscopy, immunostaining, and clinical–laboratory data are more discriminating.

Slide 55 · Histologic compartments of injury

Grey-matter pathology

Neuronal loss and reactive gliosis.

Perivascular lymphocytes and viral inclusions may occur.

White-matter pathology

Variable demyelination and astroglial sclerosis.

Oligodendroglial infection and inflammation may be detected.

True pathologic confirmation requires patient tissue—not a schematic.

Slide 56 · Inclusion bodies: What pathologists recognize

Viral inclusions may be identified in neuronal and glial nuclei or cytoplasm.

They reflect accumulated viral material, including nucleocapsid components.

Inclusions are supportive but can be focal and stage dependent.

An inclusion alone is not pathognomonic without pathogen-specific evidence.

Slide 57 · Viral inclusion concept (schematic cells)

Neuron

Oligodendrocyte

Astrocyte

Simplified cell schematic — not a histologic image

Slide 58 · Immunohistochemistry and molecular pathology

Measles antigen can be localized within infected brain cells.

In situ hybridization or tissue RNA assays may document measles viral genome.

Distribution of viral antigen and RNA can differ with stage and sampling.

Use validated laboratory methods and adequate controls; Tissue testing is not routine first line.

Slide 59 · Why brain biopsy is usually avoided

A compatible clinical course with supportive CSF and EEG evidence may suffice.

Brain biopsy is invasive and can be affected by sampling error.

Neuropathologic confirmation is considered in unusual or diagnostically unresolved cases.

Biopsy decisions require individualized risk–benefit assessment.

Slide 60 · Prognosis: Progressive and frequently fatal

SSPE causes cumulative neurologic disability in the usual course.

Most affected patients eventually become severely dependent and unresponsive.

Rapid, prolonged, and occasionally fluctuating courses are documented.

Prognostic counseling should acknowledge individual variability without minimizing severity.

Slide 61 · No established curative therapy

SSPE as lacking effective treatment.

No regimen has convincingly demonstrated a reliable cure.

Investigated approaches include inosine pranobex, interferon-α, and antivirals.

Evidence is heterogeneous; Experimental use requires specialist evaluation.

Slide 62 · How to read the treatment literature

Small cohorts and nonrandomized series limit causal conclusions.

Survival differences can reflect stage, referral, and selection bias.

Some reports describe temporary stabilization rather than eradication of disease.

Treat investigational claims separately from established standard of care.

Slide 63 · Supportive and palliative treatment

Manage seizures, myoclonus, spasticity, and pain according to clinical needs.

Address nutrition, swallowing safety, mobility, and pressure injury prevention.

Provide rehabilitation support and anticipatory guidance where appropriate.

Early family-centered goals-of-care discussion is essential in advanced illness.

Slide 64 · Prevention acts before the silent interval begins

Mechanistic sequence

Measles immunization

Avoid primary measles infection

Avoid later SSPE

Vaccination is the effective population-level prevention strategy.

Slide 65 · Case A: The diagnostic pattern

A school-age child has declining performance, personality change, recurrent sudden jerks, and a history of measles in early childhood. Routine MRI is initially unremarkable.

Discussion

Which two investigations would most directly support SSPE?

Why does a normal early MRI not rule it out?

Slide 66 · Case A: Integrated interpretation

Order CSF measles-specific antibodies, ideally with paired serum assessment.

Obtain an EEG for periodic generalized complexes and seizure characterization.

The clinical history and years-long latency substantially increase suspicion.

Normal early MRI is compatible with SSPE; Continue differential workup.

Slide 67 · Case B: An atypical presentation

An adolescent presents with progressive visual decline and episodic seizures. MRI demonstrates nonspecific posterior white-matter changes. Serum measles IgG is positive.

Discussion

Why is positive serum IgG insufficient?

What additional evidence would distinguish SSPE from its mimics?

Slide 68 · Case B: Avoid premature closure

Serum measles IgG is common after vaccination or previous infection.

Assess clinical trajectory and measles-specific intrathecal antibody evidence.

EEG may be typical, atypical, or nondiagnostic; Interpret dynamically.

Evaluate inflammatory, infectious, and autoimmune alternatives concurrently.

Slide 69 · Application: Five high-value discriminators

Delay of years after measles, not days.

Progressive cognitive or behavioral impairment, often with myoclonus.

Measles-specific CSF antibody response, not serum immunity alone.

Often periodic EEG complexes, but variable early findings.

Panencephalitis with neuronal inclusions, gliosis, and demyelination when tissue is examined.

Slide 70 · Clinicopathologic synthesis

A persistent measles-related process injures both neurons and glia.

Inflammation, demyelination, gliosis, and neuronal loss underlie progressive dysfunction.

Diagnosis combines clinical context, CSF immune evidence, and ancillary tests.

No established cure exists; Vaccination prevents the antecedent infection.

Slide 71 · Selected primary and authoritative references

Robbins, Cotran & Kumar. Pathologic Basis of Disease. 11th ed. 2026. Ch. 28, p. 1153.

CDC. Clinical Overview of Measles. Https://www.cdc.gov/measles/hcp/clinical-overview/

Jafri SK et al. Subacute sclerosing panencephalitis: Current perspectives. Pediatr Health Med Ther. 2018;9:67–71. PMC6027681.

Gutierrez J et al. Subacute sclerosing panencephalitis: An update. Dev Med Child Neurol. 2010. Doi:10.1111/j.1469-8749.2010.03717.x

Yousaf I et al. Measles virus M-F50S mutation and neuronal spread. J Virol. 2025;99:e01750-24.

Slide 72 · Further reading and evidence notes

Cattaneo R et al. How measles virus adapts to the brain. Annu Rev Virol. 2026;13:359–381. doi:10.1146/annurev-virology-100424-103230

Garg D et al. Movement disorders in SSPE: systematic review. Mov Disord Clin Pract. 2024;11:770–785.

Garg RK, Pandey S. SSPE: Recent Advances in Pathogenesis, Diagnosis, and Treatment. Ann Indian Acad Neurol. 2025;28:159–168.

Textbook scope is narrower than the supplementary review literature; edition-dependent diagnostic details are explicitly sourced in presenter notes.

Original chapter PDF and licensed histology images were not available for source-image verification in this build.